Is rasburicase needed for prevention of tumor lysis syndrome during treatment of less aggressive hematolymphoid malignancies?

MeSH terms

• Cost-Benefit Analysis
• Drug Administration Schedule
• Drug Costs
• Humans
• Hyperuricemia / drug therapy
• Hyperuricemia / etiology*
• Hyperuricemia / prevention & control*
• Leukemia / complications*
• Leukemia / drug therapy*
• Lymphoma, Non-Hodgkin / complications*
• Lymphoma, Non-Hodgkin / drug therapy*
• Recombinant Proteins
• Tumor Lysis Syndrome / etiology
• Tumor Lysis Syndrome / prevention & control*
• Urate Oxidase / administration & dosage
• Urate Oxidase / therapeutic use*